Previous Article | Next Article 
Journal of Virology, November 2007, p. 12368-12374, Vol. 81, No. 22
0022-538X/07/$08.00+0 doi:10.1128/JVI.00822-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
No Evidence for Consistent Virus-Specific Immunity in Simian Immunodeficiency Virus-Exposed, Uninfected Rhesus Monkeys
Norman L. Letvin,1,2*
Srini S. Rao,2
Vi Dang,2
Adam P. Buzby,1
Birgit Korioth-Schmitz,1
Dilani Dombagoda,1
Jenny G. Parvani,1
Ryon H. Clarke,1
Liat Bar,1
Kevin R. Carlson,1
Pamela A. Kozlowski,3
Vanessa M. Hirsch,4
John R. Mascola,2 and
Gary J. Nabel2
Division of Viral Pathogenesis, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02115,1
Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland 20892,2
Division of Gastroenterology, Department of Medicine, Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115,3
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 208924
Received 17 April 2007/
Accepted 26 July 2007
Defining the immune correlates of the protection against human immunodeficiency virus type 1 (HIV-1) acquisition in individuals who are exposed to HIV-1 but do not become infected may provide important direction for the creation of an HIV-1 vaccine. We have employed the simian immunodeficiency virus (SIV)/rhesus monkey model to determine whether monkeys can be repeatedly exposed to a primate lentivirus by a mucosal route and escape infection and whether virus-specific immune correlates of protection from infection can be identified in uninfected monkeys. Five of 18 rhesus monkeys exposed 18 times by intrarectal inoculation to SIVmac251 or SIVsmE660 were resistant to infection, indicating that the exposed/uninfected phenotype can be reproduced in a nonhuman primate AIDS model. However, routine peripheral blood lymphocyte gamma interferon enzyme-linked immunospot (ELISPOT), tetramer, and intracellular cytokine staining assays, as well as cytokine-augmented ELISPOT and peptide-stimulated tetramer assays, failed to define a systemic antigen-specific cellular immune correlate to this protection. Further, local cell-mediated immunity could not be demonstrated by tetramer assays of these protected monkeys, and local humoral immunity was not associated with protection against acquisition of virus in another cohort of mucosally exposed monkeys. Therefore, resistance to mucosal infection in these monkeys may not be mediated by adaptive virus-specific immune mechanisms. Rather, innate immune mechanisms or an intact epithelial barrier may be responsible for protection against mucosal infection in this population of monkeys.
* Corresponding author. Mailing address: Division of Viral Pathogenesis, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, RE113, P.O. Box 15732, Boston, MA 02215. Phone: (617) 667-2766. Fax: (617) 667-8210. E-mail:
nletvin{at}bidmc.harvard.edu
Published ahead of print on 8 August 2007.
Journal of Virology, November 2007, p. 12368-12374, Vol. 81, No. 22
0022-538X/07/$08.00+0 doi:10.1128/JVI.00822-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Wang, L., Cheng, C., Ko, S.-Y., Kong, W.-P., Kanekiyo, M., Einfeld, D., Schwartz, R. M., King, C. R., Gall, J. G. D., Nabel, G. J.
(2009). Delivery of Human Immunodeficiency Virus Vaccine Vectors to the Intestine Induces Enhanced Mucosal Cellular Immunity. J. Virol.
83: 7166-7175
[Abstract]
[Full Text]
-
Wilson, N. A., Keele, B. F., Reed, J. S., Piaskowski, S. M., MacNair, C. E., Bett, A. J., Liang, X., Wang, F., Thoryk, E., Heidecker, G. J., Citron, M. P., Huang, L., Lin, J., Vitelli, S., Ahn, C. D., Kaizu, M., Maness, N. J., Reynolds, M. R., Friedrich, T. C., Loffredo, J. T., Rakasz, E. G., Erickson, S., Allison, D. B., Piatak, M. Jr., Lifson, J. D., Shiver, J. W., Casimiro, D. R., Shaw, G. M., Hahn, B. H., Watkins, D. I.
(2009). Vaccine-Induced Cellular Responses Control Simian Immunodeficiency Virus Replication after Heterologous Challenge. J. Virol.
83: 6508-6521
[Abstract]
[Full Text]
-
Keele, B. F., Li, H., Learn, G. H., Hraber, P., Giorgi, E. E., Grayson, T., Sun, C., Chen, Y., Yeh, W. W., Letvin, N. L., Mascola, J. R., Nabel, G. J., Haynes, B. F., Bhattacharya, T., Perelson, A. S., Korber, B. T., Hahn, B. H., Shaw, G. M.
(2009). Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1. JEM
206: 1117-1134
[Abstract]
[Full Text]
-
Yeh, W. W., Jaru-ampornpan, P., Nevidomskyte, D., Asmal, M., Rao, S. S., Buzby, A. P., Montefiori, D. C., Korber, B. T., Letvin, N. L.
(2009). Partial Protection of Simian Immunodeficiency Virus (SIV)-Infected Rhesus Monkeys against Superinfection with a Heterologous SIV Isolate. J. Virol.
83: 2686-2696
[Abstract]
[Full Text]
-
Erickson, A. L., Willberg, C. B., McMahan, V., Liu, A., Buchbinder, S. P., Grohskopf, L. A., Grant, R. M., Nixon, D. F.
(2008). Potentially Exposed but Uninfected Individuals Produce Cytotoxic and Polyfunctional Human Immunodeficiency Virus Type 1-Specific CD8+ T-Cell Responses Which Can Be Defined to the Epitope Level. CVI
15: 1745-1748
[Abstract]
[Full Text]
-
Verhoeven, D., Sankaran, S., Silvey, M., Dandekar, S.
(2008). Antiviral Therapy during Primary Simian Immunodeficiency Virus Infection Fails To Prevent Acute Loss of CD4+ T Cells in Gut Mucosa but Enhances Their Rapid Restoration through Central Memory T Cells. J. Virol.
82: 4016-4027
[Abstract]
[Full Text]